临床相关浓度抗铜绿假单胞菌β-内酰胺类对血培养瓶检测时间及菌株生长的影响
研究评估血培养瓶中的抗菌药物结合树脂清除美罗培南、头孢洛扎-他唑巴坦和头孢他啶-阿维巴坦的效果,并观察两株铜绿假单胞菌在临床相关浓度下的检测时间与生长情况。结果显示仅 trough 浓度下两株菌均能稳定检出,建议在下次给药前采血以降低假阴性。
要点
- 仅 trough 浓度下两株铜绿假单胞菌均稳定检出。
- 美罗培南清除程度高于头孢洛扎和头孢他啶。
- 建议下次给药前采血以降低假阴性风险。
核心结论
- 含抗菌药物结合树脂的血培养瓶可能无法充分灭活美罗培南、头孢洛扎-他唑巴坦和头孢他啶-阿维巴坦的可达到浓度。
研究设计与样本
- 体外研究,将两株铜绿假单胞菌(1株美罗培南敏感、1株耐药)分别接种至 Bactec Plus Aerobic/F 和 BacT/Alert FA Plus 血培养瓶,加入含美罗培南、头孢洛扎-他唑巴坦和头孢他啶-阿维巴坦峰浓度、中点浓度或 trough 浓度的新鲜全血,监测检测时间和菌落形成单位至72小时。
主要发现
- 接种峰浓度、中点浓度和 trough 浓度的血培养瓶分别有 11/48(22.9%)、22/48(45.8%)和 47/48(97.9%)观察到细菌生长(P ≤ 0.001)。
- 当分离出铜绿假单胞菌时,检测时间通常小于26小时,Bactec 与 BacT/Alert 瓶之间未观察到差异。
- 在两种系统中,美罗培南的清除程度均高于头孢洛扎和头孢他啶;但所有抗生素浓度在12小时时仍高于敏感菌株的最低抑菌浓度。
临床怎么用
- 为减少已接受这些抗生素患者的血培养假阴性,应在下次给药前采集培养标本,此时抗生素浓度最低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The effectiveness of antimicrobial binding resins present in blood culture (BC) bottles in removing meropenem, ceftolozane-tazobactam, and ceftazidime-avibactam is unknown. We assessed the time to detection (TTD) and growth of 2 Pseudomonas aeruginosa isolates in the presence of clinically meaningful concentrations of these antibiotics. Bactec Plus Aerobic/F and BacT/Alert FA Plus BC bottles were inoculated with one of two isolates (1 meropenem susceptible and 1 resistant), followed by fresh whole blood containing the peak, midpoint, or trough plasma concentrations for meropenem, ceftolozane-tazobactam, and ceftazidime-avibactam. Matching bottles were loaded into their respective detection instruments and a standard incubator at 37°C, with TTD and CFU being monitored for up to 72 h. Bacterial growth was observed for 11/48 (22.9%), 22/48 (45.8%), and 47/48 (97.9%) of all BC bottles inoculated with the peak, midpoint, and trough concentrations, respectively (P ≤ 0.001). When P. aeruginosa was isolated, the TTD was typically <26 h, and no differences between Bactec and BacT/Alert bottles were observed. In both systems, meropenem was removed to a greater degree than were ceftolozane and ceftazidime; however, concentrations for all antibiotics remained above the MIC for the susceptible organisms at 12 h. BC bottles containing antibiotic binding resins may not sufficiently inactivate achievable concentrations of meropenem, ceftolozane-tazobactam, and ceftazidime-avibactam. The consistent identification of both P. aeruginosa isolates was observed only in the presence of antibiotic trough concentrations. To minimize false-negative BC results for patients already receiving these antibiotics, cultures should be collected just prior to the next dose, when antibiotic concentrations are lowest.
引用
- Grupper M, Nicolau DP, Aslanzadeh J, et al. Effects of Clinically Meaningful Concentrations of Antipseudomonal β-Lactams on Time to Detection and Organism Growth in Blood Culture Bottles. J Clin Microbiol. 2017. PMID: 29021155. doi:10.1128/JCM.01241-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。